Danone (OTCMKTS:DANOY) Sees Large Volume Increase – Here’s What Happened

Danone (OTCMKTS:DANOY) shares saw strong trading volume on Thursday . 642,175 shares traded hands during trading, an increase of 20% from the previous session’s volume of 536,475 shares.The stock last traded at $16.17 and had previously closed at $15.87.

Analyst Ratings Changes

Several equities research analysts have recently commented on DANOY shares. Deutsche Bank Aktiengesellschaft cut Danone from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Citigroup reissued a “neutral” rating on shares of Danone in a research note on Wednesday, October 29th. Morgan Stanley reiterated an “overweight” rating on shares of Danone in a report on Friday, October 10th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating on shares of Danone in a research report on Wednesday, October 29th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Danone Price Performance

The firm’s fifty day moving average price is $17.76 and its 200-day moving average price is $17.34. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.95.

About Danone

Danone is a French multinational food-products company headquartered in Paris, with roots dating to 1919 when it was founded by Isaac Carasso. The company positions itself around nutrition and health-oriented food and beverage products, and it combines global brand management, manufacturing and distribution to serve a broad consumer base. Danone’s long history has been characterized by expansion beyond its original yogurt business into bottled water, infant and medical nutrition, and plant-based alternatives.

Danone’s principal activities include the development, production and marketing of dairy and plant-based products, bottled waters, and specialized nutrition for infants and medical patients.